{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:29:44Z","timestamp":1794551384231,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was funded by a grant from Flow Neuroscience to the overall study Chief Investigator and UK PI to C.H.Y.F., and to the USA PI, S.S."},{"name":"Authors D.M. and L.H. work for Biomedical Statistical Consulting, who provides statistical support to MCRA, LLC who received payments from Flow Neuroscience."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Transcranial direct current stimulation (tDCS) has been proposed as a new treatment in major depressive disorder (MDD). This is a fully remote, multisite, double-blind, placebo-controlled, randomized superiority trial of 10-week home-based tDCS in MDD. Participants were 18 years or older, with MDD in current depressive episode of at least moderate severity as measured using the Hamilton Depression Rating Scale (mean\u2009=\u200919.07\u2009\u00b1\u20092.73). A total of 174 participants (120 women, 54 men) were randomized to active (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200987, mean age\u2009=\u200937.09\u2009\u00b1\u200911.14 years) or sham (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200987, mean age\u2009=\u200938.32\u2009\u00b1\u200910.92 years) treatment. tDCS consisted of five sessions per week for 3 weeks then three sessions per week for 7 weeks in a 10-week trial, followed by a 10-week open-label phase. Each session lasted 30\u2009min; the anode was placed over the left dorsolateral prefrontal cortex and the cathode over the right dorsolateral prefrontal cortex (active tDCS 2\u2009mA and sham tDCS 0\u2009mA, with brief ramp up and down to mimic active stimulation). As the primary outcome, depressive symptoms showed significant improvement when measured using the Hamilton Depression Rating Scale: active 9.41\u2009\u00b1\u20096.25 point improvement (10-week mean\u2009=\u20099.58\u2009\u00b1\u20096.02) and sham 7.14\u2009\u00b1\u20096.10 point improvement (10-week mean\u2009=\u200911.66\u2009\u00b1\u20095.96) (95% confidence interval\u2009=\u20090.51\u20134.01,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.012). There were no differences in discontinuation rates. In summary, a 10-week home-based tDCS treatment with remote supervision in MDD showed high efficacy, acceptability and safety. ClinicalTrials.gov registration:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05202119\" ext-link-type=\"uri\">NCT05202119<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.1038\/s41591-024-03305-y","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:03:25Z","timestamp":1729512205000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5581-9449","authenticated-orcid":false,"given":"Rachel D.","family":"Woodham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Lajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Hobday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Reza","family":"Ghazi-Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-0563","authenticated-orcid":false,"given":"Sarah S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Orhii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maislin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Machado-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4313-3500","authenticated-orcid":false,"given":"Cynthia H. Y.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"3305_CR1","unstructured":"World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates (2017); https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/254610\/WHO-MSD-MER-2017.2-eng.pdf"},{"key":"3305_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jad.2014.02.026","volume":"159","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers, P. et al. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J. Affect. Disord. 159, 118\u2013126 (2014).","journal-title":"J. Affect. Disord."},{"key":"3305_CR3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"3305_CR4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/09540261.2021.1879030","volume":"33","author":"R Woodham","year":"2021","unstructured":"Woodham, R., Rimmer, R. M., Mutz, J. & Fu, C. H. Y. Is tDCS a potential first line treatment for major depression? Int. Rev. Psychiatry 33, 250\u2013265 (2021).","journal-title":"Int. Rev. Psychiatry"},{"key":"3305_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0014-4886(62)90056-0","volume":"5","author":"OD Creutzfeldt","year":"1962","unstructured":"Creutzfeldt, O. D., Fromm, G. H. & Kapp, H. Influence of transcortical d-c currents on cortical neuronal activity. Exp. Neurol. 5, 436\u2013452 (1962).","journal-title":"Exp. Neurol."},{"key":"3305_CR6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/bmj.l1079","volume":"364","author":"J Mutz","year":"2019","unstructured":"Mutz, J. et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ 364, 1079 (2019).","journal-title":"BMJ"},{"key":"3305_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1113\/jphysiol.2003.049916","volume":"553","author":"MA Nitsche","year":"2003","unstructured":"Nitsche, M. A. et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J. Physiol. 553, 293\u2013301 (2003).","journal-title":"J. Physiol."},{"key":"3305_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.brs.2012.04.011","volume":"6","author":"K Monte-Silva","year":"2013","unstructured":"Monte-Silva, K. et al. Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation. Brain Stimul. 6, 424\u2013432 (2013).","journal-title":"Brain Stimul."},{"key":"3305_CR9","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1523\/JNEUROSCI.2059-10.2010","volume":"30","author":"D Reato","year":"2010","unstructured":"Reato, D., Rahman, A., Bikson, M. & Parra, L. C. Low-intensity electrical stimulation affects network dynamics by modulating population rate and spike timing. J. Neurosci. 30, 15067\u201315079 (2010).","journal-title":"J. Neurosci."},{"key":"3305_CR10","doi-asserted-by":"crossref","first-page":"15284","DOI":"10.1523\/JNEUROSCI.0542-11.2011","volume":"31","author":"D Keeser","year":"2011","unstructured":"Keeser, D. et al. Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI. J. Neurosci. 31, 15284\u201315293 (2011).","journal-title":"J. Neurosci."},{"key":"3305_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamapsychiatry.2018.2172","volume":"76","author":"M Ironside","year":"2019","unstructured":"Ironside, M. et al. Effect of prefrontal cortex stimulation on regulation of amygdala response to threat in individuals with trait anxiety: a randomized clinical trial. JAMA Psychiatry 76, 71\u201378 (2019).","journal-title":"JAMA Psychiatry"},{"key":"3305_CR12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109836","volume":"99","author":"AH Moffa","year":"2020","unstructured":"Moffa, A. H. et al. Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: an individual patient data meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 99, 109836 (2020).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3305_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpsychires.2022.07.026","volume":"153","author":"R Woodham","year":"2022","unstructured":"Woodham, R., Rimmer, R. M., Young, A. H. & Fu, C. H. Y. Adjunctive home-based transcranial direct current stimulation treatment for major depression with real-time remote supervision: an open-label, single-arm feasibility study with long term outcomes. J. Psychiatr. Res. 153, 197\u2013205 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"3305_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jad.2019.04.041","volume":"252","author":"A Alonzo","year":"2019","unstructured":"Alonzo, A. et al. Pilot trial of home-administered transcranial direct current stimulation for the treatment of depression. J. Affect. Disord. 252, 475\u2013483 (2019).","journal-title":"J. Affect. Disord."},{"key":"3305_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2021.04.013","volume":"288","author":"L Borrione","year":"2021","unstructured":"Borrione, L., Klein, I., Razza, L. B., Suen, P. & Brunoni, A. R. Use of app-based psychological interventions in combination with home-use transcranial direct current stimulation for the treatment of major depressive disorder: a case series. J. Affect. Disord. 288, 189\u2013190 (2021).","journal-title":"J. Affect. Disord."},{"key":"3305_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1108\/MHRJ-07-2022-0050","volume":"29","author":"RM Rimmer","year":"2024","unstructured":"Rimmer, R. M., Woodham, R. D., Cahill, S. & Fu, C. H. Y. Acceptability of home-based transcranial direct current stimulation (tDCS) in major depression: a qualitative analysis of individual experiences. Ment. Health Rev. J. 29, 79\u201391 (2024).","journal-title":"Ment. Health Rev. J."},{"key":"3305_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jamapsychiatry.2023.4948","volume":"81","author":"L Borrione","year":"2024","unstructured":"Borrione, L. et al. Home-use transcranial direct current stimulation for the treatment of a major depressive episode: a randomized clinical trial. JAMA Psychiatry 81, 329\u2013337 (2024).","journal-title":"JAMA Psychiatry"},{"key":"3305_CR18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00406-023-01620-y","volume":"273","author":"U Kumpf","year":"2023","unstructured":"Kumpf, U. et al. TDCS at home for depressive disorders: an updated systematic review and lessons learned from a prematurely terminated randomized controlled pilot study. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1403\u20131420 (2023).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"3305_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.9758\/cpn.2022.20.1.87","volume":"20","author":"J Oh","year":"2022","unstructured":"Oh, J., Jang, K.-I., Jeon, S. & Chae, J.-H. Effect of self-administered transcranial direct stimulation in patients with major depressive disorder: a randomized, single-blinded clinical trial. Clin. Psychopharmacol. Neurosci. 20, 87\u201396 (2022).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"3305_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110752","volume":"125","author":"S Nikolin","year":"2023","unstructured":"Nikolin, S. et al. Time-course of the tDCS antidepressant effect: an individual participant data meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 125, 110752 (2023).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3305_CR21","doi-asserted-by":"crossref","unstructured":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3305_CR22","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59, 22\u201333 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"3305_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"3305_CR24","doi-asserted-by":"crossref","first-page":"k4218","DOI":"10.1136\/bmj.k4218","volume":"363","author":"DS Kessler","year":"2018","unstructured":"Kessler, D. S. et al. Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ 363, k4218 (2018).","journal-title":"BMJ"},{"key":"3305_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18310","volume":"18","author":"N Wiles","year":"2014","unstructured":"Wiles, N. et al. Clinical and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol. Assess. 18, 1\u2013167 (2014).","journal-title":"Health Technol. Assess."},{"key":"3305_CR26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery, S. A. & \u00c5sberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382\u2013389 (1979).","journal-title":"Br. J. Psychiatry"},{"key":"3305_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0327(00)00242-1","volume":"64","author":"P Svanborg","year":"2001","unstructured":"Svanborg, P. & \u00c5sberg, M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery \u00c5sberg Depression Rating Scale (MADRS). J. Affect. Disord. 64, 203\u2013216 (2001).","journal-title":"J. Affect. Disord."},{"key":"3305_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50\u201355 (1959).","journal-title":"Br. J. Med. Psychol."},{"key":"3305_CR29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429\u2013435 (1978).","journal-title":"Br. J. Psychiatry"},{"key":"3305_CR30","unstructured":"Rey, A. L\u2019Examen Clinique En Psychologie (Presses Universitaires de France, 1964)."},{"key":"3305_CR31","unstructured":"Smith, A. Symbol Digit Modalities Test (Western Psychological Services, 1991)."},{"key":"3305_CR32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.bp.115.164715","volume":"208","author":"AR Brunoni","year":"2016","unstructured":"Brunoni, A. R. et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br. J. Psychiatry 208, 522\u2013531 (2016).","journal-title":"Br. J. Psychiatry"},{"key":"3305_CR33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2015.07.012","volume":"57","author":"D Meron","year":"2015","unstructured":"Meron, D., Hedger, N., Garner, M. & Baldwin, D. S. Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability. Neurosci. Biobehav. Rev. 57, 46\u201362 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"3305_CR34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neubiorev.2018.05.015","volume":"92","author":"J Mutz","year":"2018","unstructured":"Mutz, J., Edgcumbe, D. R., Brunoni, A. R. & Fu, C. H. Y. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of randomised sham-controlled trials. Neurosci. Biobehav. Rev. 92, 291\u2013303 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"3305_CR35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(23)00640-2","volume":"402","author":"G Burkhardt","year":"2023","unstructured":"Burkhardt, G. et al. Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial. Lancet 402, 545\u2013554 (2023).","journal-title":"Lancet"},{"key":"3305_CR36","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1056\/NEJMoa1612999","volume":"376","author":"AR Brunoni","year":"2017","unstructured":"Brunoni, A. R. et al. Trial of electrical direct-current therapy versus escitalopram for depression. N. Engl. J. Med. 376, 2523\u20132533 (2017).","journal-title":"N. Engl. J. Med."},{"key":"3305_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brs.2009.04.002","volume":"3","author":"E Frank","year":"2010","unstructured":"Frank, E. et al. Anodal skin lesions after treatment with transcranial direct current stimulation. Brain Stimul. 3, 58\u201359 (2010).","journal-title":"Brain Stimul."},{"key":"3305_CR38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brs.2018.10.018","volume":"12","author":"A Kortteenniemi","year":"2019","unstructured":"Kortteenniemi, A., Lehto, S. M. & Javadi, A.-H. Delayed, distant skin lesions after transcranial direct current stimulation. Brain Stimul. 12, 204\u2013206 (2019).","journal-title":"Brain Stimul."},{"key":"3305_CR39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1017\/S1461145710001690","volume":"14","author":"AR Brunoni","year":"2011","unstructured":"Brunoni, A. R. et al. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int. J. Neuropsychopharmacol. 14, 1133\u20131145 (2011).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"3305_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.06.021","volume":"221","author":"AH Moffa","year":"2017","unstructured":"Moffa, A. H. et al. Safety and acceptability of transcranial direct current stimulation for the acute treatment of major depressive episodes: analysis of individual patient data. J. Affect. Disord. 221, 1\u20135 (2017).","journal-title":"J. Affect. Disord."},{"key":"3305_CR41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pnpbp.2018.10.006","volume":"89","author":"AV Sathappan","year":"2019","unstructured":"Sathappan, A. V., Luber, B. M. & Lisanby, S. H. The dynamic duo: combining noninvasive brain stimulation with cognitive interventions. Prog. Neuropsychopharmacol. Biol. Psychiatry 89, 347\u2013360 (2019).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3305_CR42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.brs.2018.12.003","volume":"12","author":"DR Edgcumbe","year":"2019","unstructured":"Edgcumbe, D. R., Thoma, V., Rivolta, D., Nitsche, M. A. & Fu, C. H. Y. Anodal transcranial direct current stimulation over the right dorsolateral prefrontal cortex enhances reflective judgment and decision-making. Brain Stimul. 12, 652\u2013658 (2019).","journal-title":"Brain Stimul."},{"key":"3305_CR43","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/cercor\/bhx021","volume":"28","author":"A Pisoni","year":"2018","unstructured":"Pisoni, A. et al. Cognitive enhancement induced by anodal tDCS drives circuit-specific cortical plasticity. Cereb. Cortex 28, 1132\u20131140 (2018).","journal-title":"Cereb. Cortex"},{"key":"3305_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.brs.2013.12.008","volume":"7","author":"RA Segrave","year":"2014","unstructured":"Segrave, R. A., Arnold, S., Hoy, K. & Fitzgerald, P. B. Concurrent cognitive control training augments the antidepressant efficacy of tDCS: a pilot study. Brain Stimul. 7, 325\u2013331 (2014).","journal-title":"Brain Stimul."},{"key":"3305_CR45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamapsychiatry.2022.0696","volume":"79","author":"S Aust","year":"2022","unstructured":"Aust, S. et al. Efficacy of augmentation of cognitive behavioral therapy with transcranial direct current stimulation for depression. JAMA Psychiatry 79, 528\u2013537 (2022).","journal-title":"JAMA Psychiatry"},{"key":"3305_CR46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0528.2009.00494.x","volume":"37","author":"J Kolahi","year":"2009","unstructured":"Kolahi, J., Bang, H. & Park, J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent. Oral Epidemiol. 37, 477\u2013484 (2009).","journal-title":"Community Dent. Oral Epidemiol."},{"key":"3305_CR47","doi-asserted-by":"crossref","first-page":"e072108","DOI":"10.1136\/bmj-2022-072108","volume":"381","author":"D Hohenschurz-Schmidt","year":"2023","unstructured":"Hohenschurz-Schmidt, D. et al. Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement. BMJ 381, e072108 (2023).","journal-title":"BMJ"},{"key":"3305_CR48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000510738","volume":"90","author":"AWM Evers","year":"2021","unstructured":"Evers, A. W. M. et al. What should clinicians tell patients about placebo and nocebo effects? Practical considerations based on expert consensus. Psychother. Psychosom. 90, 49\u201356 (2021).","journal-title":"Psychother. Psychosom."},{"key":"3305_CR49","volume":"50","author":"Y-H Lin","year":"2022","unstructured":"Lin, Y.-H. et al. Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000\u20132020: a systematic review and meta-analysis. eClinicalMedicine 50, 101505 (2022).","journal-title":"eClinicalMedicine"},{"key":"3305_CR50","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher, D. et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340, c869 (2010).","journal-title":"BMJ"},{"key":"3305_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","volume":"25","author":"H Bang","year":"2004","unstructured":"Bang, H., Ni, L. & Davis, C. E. Assessment of blinding in clinical trials. Control. Clin. Trials 25, 143\u2013156 (2004).","journal-title":"Control. Clin. Trials"},{"key":"3305_CR52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17434440.2020.1813565","volume":"17","author":"L Borrione","year":"2020","unstructured":"Borrione, L. et al. The Flow brain stimulation headset for the treatment of depression: overview of its safety, efficacy and portable design. Expert Rev. Med. Devices 17, 867\u2013878 (2020).","journal-title":"Expert Rev. Med. Devices"},{"key":"3305_CR53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroimage.2015.01.033","volume":"109","author":"A Opitz","year":"2015","unstructured":"Opitz, A., Paulus, W., Will, S., Antunes, A. & Thielscher, A. Determinants of the electric field during transcranial direct current stimulation. Neuroimage 109, 140\u2013150 (2015).","journal-title":"Neuroimage"},{"key":"3305_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37226-x","volume":"9","author":"I Laakso","year":"2019","unstructured":"Laakso, I., Mikkonen, M., Koyama, S., Hirata, A. & Tanaka, S. Can electric fields explain inter-individual variability in transcranial direct current stimulation of the motor cortex? Sci. Rep. 9, 626 (2019).","journal-title":"Sci. Rep."},{"key":"3305_CR55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1258\/1357633041424368","volume":"10","author":"KA Kobak","year":"2004","unstructured":"Kobak, K. A. A comparison of face-to-face and videoconference administration of the Hamilton Depression Rating Scale. J. Telemed. Telecare 10, 231\u2013235 (2004).","journal-title":"J. Telemed. Telecare"},{"key":"3305_CR56","doi-asserted-by":"crossref","first-page":"e38955","DOI":"10.2196\/38955","volume":"10","author":"CE Schiller","year":"2023","unstructured":"Schiller, C. E. et al. Efficacy of virtual care for depressive disorders: systematic review and meta-analysis. JMIR Ment. Health 10, e38955 (2023).","journal-title":"JMIR Ment. Health"},{"key":"3305_CR57","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1017\/S0033291722002331","volume":"52","author":"AM Scott","year":"2022","unstructured":"Scott, A. M. et al. Telehealth v. face-to-face provision of care to patients with depression: a systematic review and meta-analysis. Psychol. Med. 52, 2852\u20132860 (2022).","journal-title":"Psychol. Med."},{"key":"3305_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R. EuroQol: the current state of play. Health Policy 37, 53\u201372 (1996).","journal-title":"Health Policy"},{"key":"3305_CR59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R. & de Charro, F. EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 33, 337\u2013343 (2001).","journal-title":"Ann. Med."},{"key":"3305_CR60","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner, K. et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am. J. Psychiatry 168, 1266\u20131277 (2011).","journal-title":"Am. J. Psychiatry"},{"key":"3305_CR61","volume":"1","author":"S Heidari","year":"2016","unstructured":"Heidari, S., Babor, T. F., De Castro, P., Tort, S. & Curno, M. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res. Integr. Peer Rev. 1, 2 (2016).","journal-title":"Res. Integr. Peer Rev."},{"key":"3305_CR62","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/sim.2151","volume":"24","author":"JM Lachin","year":"2005","unstructured":"Lachin, J. M. A review of methods for futility stopping based on conditional power. Stat. Med. 24, 2747\u20132764 (2005).","journal-title":"Stat. Med."},{"key":"3305_CR63","unstructured":"Keenan, B. T. & Maislin, G. The use of \u2018Fuzzy Promising Zones\u2019 to mitigate against operational bias in adaptive sample size re-estimation designs. In Proc. JSM 2014 (ed. Opsomer, J. D.) 1493\u20131505 (American Statistical Association, 2014)."},{"key":"3305_CR64","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/bimj.201700308","volume":"61","author":"ST Hsiao","year":"2019","unstructured":"Hsiao, S. T., Liu, L. & Mehta, C. R. Optimal promising zone designs. Biom. J. 61, 1175\u20131186 (2019).","journal-title":"Biom. J."},{"key":"3305_CR65","doi-asserted-by":"crossref","unstructured":"Verbeke, G. & Molenberghs, G. Linear Mixed Models for Longitudinal Data (Springer, 2000).","DOI":"10.1007\/978-1-4419-0300-6"},{"key":"3305_CR66","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"Y Hochberg","year":"1988","unstructured":"Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75, 800\u2013802 (1988).","journal-title":"Biometrika"},{"key":"3305_CR67","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1002\/sim.5990","volume":"32","author":"A Dmitrienko","year":"2013","unstructured":"Dmitrienko, A. & D\u2019Agostino, R. Sr Traditional multiplicity adjustment methods in clinical trials. Stat. Med. 32, 5172\u20135218 (2013).","journal-title":"Stat. Med."},{"key":"3305_CR68","unstructured":"Higgins, J. et al. (eds) Cochrane Handbook for Systematic Reviews of Interventions (Wiley, 2023)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03305-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T18:04:39Z","timestamp":1737482679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03305-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1038\/s41591-024-03305-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.27.23299059","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H.Y.F. reports the following competing interests: research grant funding on behalf of the University of East London from Flow Neuroscience (no. R102696); research grant funding from NIMH (no. R01MH134236), the Baszucki Brain Research Fund Milken Institute (no. BD0000009), the Rosetrees Trust (no. CF20212104), the International Psychoanalytic Society (no. 158102845), the MRC (no. G0802594), NARSAD and the Wellcome Trust. She is Associate Editor of\n                      Psychoradiology\n                      and Section Editor of the\n                      Brain Research Bulletin\n                      . A.H.Y. reports the following competing interests: paid lectures and advisory boards for the following companies with therapies used in affective and related disorders: Flow Neuroscience, Novartis, Roche, Janssen, Takeda, Noema Pharma, Compass, AstraZeneca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, LivaNova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, Sage, Novartis and Neurocentrx. He is principal investigator for the following studies: the Restore-Life VNS registry study funded by LivaNova; ESKETINTRD3004: \u2018An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression\u2019; The Effects of Psilocybin on Cognitive Function in Healthy Participants; The Safety and Efficacy of Psilocybin in Participants with Treatment-Resistant Depression (P-TRD); A Double-Blind, Randomized, Parallel-Group Study with Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20\u2009mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy (Janssen); An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants with Major Depressive Disorder (MDD) (Janssen); A Randomized, Double-blind, Multicentre, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10\u2009mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy; A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNR (Janssen). He is UK Chief Investigator for the following studies: Novartis MDD study no. MIJ821A12201; Compass; and the COMP006 and COMP007 studies. Grant funding (past and present) includes: NIMH (USA); CIHR (Canada); NARSAD (USA); the Stanley Medical Research Institute (USA); MRC (UK); the Wellcome Trust (UK); the Royal College of Physicians of Edinburgh; the British Medical Association (UK); the VGH & UBC Foundation (Canada); WEDC (Canada); the CCS Depression Research Fund (Canada); the Michael Smith Foundation for Health Research (Canada); NIHR (UK). Janssen (UK) and EU Horizon 2020. He is the Editor of the\n                      Journal of Psychopharmacology\n                      and Deputy Editor of\n                      BJPsych Open\n                      . He has no shareholdings in pharmaceutical companies. S.S. reports the following competing interests: research grant funding on behalf of the University of Texas Health Science Center at Houston from Flow Neuroscience; paid advisory boards for the following companies: Worldwide Clinical Trials and Inversago; and Vicore Pharma. He is a full-time employee of Intra-Cellular Therapies. He has received grants and research support from NIMH (USA) (no. 1R21MH119441-01A1), NIMH (no. 1R21MH129888-01A1), NICHD (no. 1R21HD106779-01A1), SAMHSA (no. 6H79FG000470-01M003) and Fizer foundation. He has received research funding as a principal investigator or study\/subinvestigator from or participated as consultant\/speaker for Flow Neuroscience, COMPASS Pathways, LivaNova, Janssen, Relmada and the Psychiatry Education Forum. Intra-Cellular Therapies or National Institutes of Health (NIH) or SAMHSA or any other organizations had no role in study design and conduct; the collection, management, analysis and interpretation of the data; the preparation, review or approval of the manuscript; and the decision to submit the manuscript for publication. The study\u2019s content is solely the responsibility of the authors and does not necessarily represent the official views of the Intra-Cellular Therapies or NIH or SAMHSA. R.M-V. has received consulting fees from Eurofarma Pharmaceuticals, Abbott and BioStrategies group; has research contracts with Boerhinger Ingelheim and Janssen Pharmaceuticals; and has received speaker fees from Otsuka, EMS and Cristalia. He is a member of the scientific boards of Symbinas Pharmaceuticals and Allergan. He is also the principal investigator for the following grants: NIH (nos. R21HD106779 and R21MH129888), Milken Institute (no. BD-0000000081). D.M. and L.H. work for Biomedical Statistical Consulting; they provide statistical support to MCRA and received payments from Flow Neuroscience. A.-R.G.-N., G.S., H.H., J.C.S., M.R., N.L., P.J.L., P.O., R.D.W. and S.S.K. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}